Compliance of systematic reviews articles in brain arteriovenous malformation with PRISMA statement guidelines: Review of literature
- 26 February 2017
- journal article
- review article
- Published by Elsevier BV in Journal of Clinical Neuroscience
- Vol. 39, 45-48
- https://doi.org/10.1016/j.jocn.2017.02.016
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trialThe Lancet, 2013
- A PRISMA assessment of the reporting quality of systematic reviews in orthodonticsAngle Orthodontist, 2012
- Treatment of Brain Arteriovenous MalformationsJAMA, 2011
- Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication biasJournal of Cranio-Maxillofacial Surgery, 2010
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationJournal of Clinical Epidemiology, 2009
- AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviewsJournal of Clinical Epidemiology, 2009
- Epidemiology and Reporting Characteristics of Systematic ReviewsPLoS Medicine, 2007
- Number of published systematic reviews and global burden of disease: database analysisBMJ, 2003
- Evidence based medicine: what it is and what it isn'tBMJ, 1996